# Sample Collection for Ongoing Research and Product Evaluation Study

> **NCT07318051** · — · RECRUITING · sponsor: **Natera, Inc.** · enrollment: 9600 (estimated)

## Conditions studied

- Breast Cancer
- Lung Cancer
- Muscle Invasive Bladder Cancer
- Rectal Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Gastroesophageal Cancer
- Prostate Cancer
- Melanoma
- Head and Neck Cancer
- Uterine Cancer
- Liver Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07318051
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2035-01
- **Final completion:** 2035-01
- **Target enrollment:** 9600 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318051, "Sample Collection for Ongoing Research and Product Evaluation Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07318051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*